[1]
2025. CRISPR/Cas9-Mediated Reprogramming of Medicinal Plants for Enhanced Anti-Cancer Bioactive Compounds “Advances in Genome Editing for Plant-Derived Therapeutics”. Journal of Carcinogenesis. 24, 3 (Sep. 2025), 350–356. DOI:https://doi.org/10.64149/J.Carcinog.24.3.350-356.